References
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
- Tsimafeyeu I, Aksel E. Renal Cell Carcinoma in the Russian Federation in 2008. Malign Tumours 2010;1:1–4.
- Karumanchi SA, Merchan J, Sukhatme VP. Renal cancer: molecular mechanisms and newer therapeutic options. Curr Opin Nephrol Hypertens 2002;11:37–42.
- DeVita VT, Hellman S, Rosenberg SA. Cancer principles and practice of oncology. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
- Bastien L, Culine S, Paule B, Ledbai S, Patard JJ, de la Taille A. Targeted therapies in metastatic renal cancer in 2009. BJU Int 2009;103:1334–42.
- Dailey L, Ambrosetti D, Mansukhani A, Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 2005;16:233–47.
- Ribatti D, Vacca A, Rusnati M, Presta M. The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev 2007;18:327–34.
- Mohammadi M, Olsen SK, Ibrahimi OA. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 2005;16:107–37.
- Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E. Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res 1999;19:1537–40.
- Izawa JI, Dinney CP. The role of angiogenesis in prostate and other urologic cancers: a review. CMAJ 2001;164:662–70.
- Poon RT, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001;19:1207–25.
- Cronauer MV, Schulz WA, Seifert HH, Ackermann R, Burchardt M. Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol 2003;43:309–19.
- Duensing S, Grosse J, Atzpodien J. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients. Anticancer Res 1995;15:2331–3.
- Horstmann M, Merseburger AS, von der Heyde E, Serth J, Wegener G, Mengel M, Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels. J Cancer Res Clin Oncol 2005;131:715–22.
- Rini BI, Atkins MB. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 2009;10:992–1000.
- Ornitz DM, Nobuyuki I. Fibroblast growth factors. Genome Biol 2001;2(3): reviews3005.1–12.
- Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Distinct Role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. AmJPathol 2003;162:1913–26.
- Powell AK, Fernig DG, Turnbull JE. Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. JBiolChem 2002;277:28554–63.
- Kuhn H, Kopff C, Konrad J, Riedel A, Gessner C, Wirtz H. Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines. Lung Cancer 2004;44:167–74.
- Takanami I, Tanaka F, Hashizume T, Kodaira S. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasm 1997;44:295–8.
- Ito H, Oshita F, Kameda Y, Suzuki R, Ikehara M, Arai H, Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas. Oncol Rep 2002;9:119–23.
- Behrens C, Lin H, Lee J, Raso MG, Hong WK, Wistuba II, Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer. Clin Cancer Res 2008;14:6014–22.
- Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J, Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann Oncol 1999;10:707–13.